Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study.

MLA

Taher, Ali, et al. “Achieving Treatment Goals of Reducing or Maintaining Body Iron Burden with Deferasirox in Patients with β-Thalassaemia: Results from the ESCALATOR Study.” European Journal of Haematology, vol. 87, no. 4, Oct. 2011, pp. 349–54. EBSCOhost, https://doi.org/10.1111/j.1600-0609.2011.01661.x.

APA

Taher, A., Elalfy, M. S., Al Zir, K., Daar, S., Al Jefri, A., Habr, D., Kriemler-Krahn, U., Roubert, B., & El-Beshlawy, A. (2011). Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study. European Journal of Haematology, 87(4), 349–354. https://doi.org/10.1111/j.1600-0609.2011.01661.x

Chicago

Taher, Ali, Mohsen S Elalfy, Kusai Al Zir, Shahina Daar, Abdullah Al Jefri, Dany Habr, Ulrike Kriemler-Krahn, Bernard Roubert, and Amal El-Beshlawy. 2011. “Achieving Treatment Goals of Reducing or Maintaining Body Iron Burden with Deferasirox in Patients with β-Thalassaemia: Results from the ESCALATOR Study.” European Journal of Haematology 87 (4): 349–54. doi:10.1111/j.1600-0609.2011.01661.x.